Gene therapy strategies to exploit TRIM derived restriction factors against HIV-1.
about
Targeting the latent reservoir to achieve functional HIV cureCellular and viral determinants of retroviral nuclear entryBone Marrow Gene Therapy for HIV/AIDSPotent restriction of HIV-1 and SIVmac239 replication by African green monkey TRIM5α.African green monkey TRIM5α restriction in simian immunodeficiency virus-specific rhesus macaque effector CD4 T cells enhances their survival and antiviral function.Expression levels of Fv1: effects on retroviral restriction specificities.Enhancing titres of therapeutic viral vectors using the transgene repression in vector production (TRiP) system.Potential mechanisms for cell-based gene therapy to treat HIV/AIDS.The innate immune roles of host factors TRIM5α and Cyclophilin A on HIV-1 replication.Stem cell-based therapies for HIV/AIDS.TRIM59 is a novel potential prognostic biomarker in patients with non-small cell lung cancer: A research based on bioinformatics analysisTRIM66 expression in non-small cell lung cancer: A new predictor of prognosis.Implication of Different HIV-1 Genes in the Modulation of Autophagy.Proteasome Inhibition Increases the Efficiency of Lentiviral Vector-Mediated Transduction of Trabecular Meshwork.Prospects in Innate Immune Responses as Potential Control Strategies against Non-Primate LentivirusesModulated expression of the HIV-1 2LTR zinc finger efficiently interferes with the HIV integration process
P2860
Q26745923-A682FA50-4A19-4BAF-9383-F33058B40657Q26778299-CEDE9B1F-AD91-490B-92F6-D03D3522556DQ26801765-A6158EB5-E4A3-4743-9F72-059A44A9B797Q35142600-776395F0-5DE1-4AE3-BED6-C7EE73649AFDQ35641022-F8640348-4B3E-48AF-8D1F-CD8E1872116CQ37037995-293EEF1E-9599-47C6-9D36-3F8C86476191Q37736299-9C8CB8BC-293F-4772-BE06-81157773F048Q38267240-41803312-F797-405F-B41A-4FF0E8B83C64Q38430710-18F4AE04-2180-409D-8178-BD9B894C8E4EQ38827119-7938CF4F-2315-49B9-9802-0325CD4A9E5AQ41144441-0C0B18D1-8E07-4368-AFED-7A7FAEC1B0D4Q41930622-CABBFAE7-CB6F-4A4D-A87B-C9F1D658BF3FQ47136487-B0EAC0DE-D5F2-4A9C-9BF5-469BB0B9DD54Q47552653-4D9BA374-DA4A-4191-ABD7-69692869E013Q56977004-FE68108F-1A95-4907-9E22-D4DEF9D04F9AQ58760373-1ADE34EF-93C7-4F9C-8D7A-377BDBD8A761
P2860
Gene therapy strategies to exploit TRIM derived restriction factors against HIV-1.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gene therapy strategies to exploit TRIM derived restriction factors against HIV-1.
@en
Gene therapy strategies to exploit TRIM derived restriction factors against HIV-1.
@nl
type
label
Gene therapy strategies to exploit TRIM derived restriction factors against HIV-1.
@en
Gene therapy strategies to exploit TRIM derived restriction factors against HIV-1.
@nl
prefLabel
Gene therapy strategies to exploit TRIM derived restriction factors against HIV-1.
@en
Gene therapy strategies to exploit TRIM derived restriction factors against HIV-1.
@nl
P2860
P921
P356
P1433
P1476
Gene therapy strategies to exploit TRIM derived restriction factors against HIV-1.
@en
P2093
P2860
P304
P356
10.3390/V6010243
P5008
P577
2014-01-14T00:00:00Z